These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31473845)

  • 1. Recent Advances in Pharmacological Treatments of Adult Dermatomyositis.
    Chen KL; Zeidi M; Werth VP
    Curr Rheumatol Rep; 2019 Aug; 21(10):53. PubMed ID: 31473845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
    Go DJ; Park JK; Kang EH; Kwon HM; Lee YJ; Song YW; Lee EB
    Rheumatol Int; 2016 Jan; 36(1):125-31. PubMed ID: 26223808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis.
    Mukae H; Ishimoto H; Sakamoto N; Hara S; Kakugawa T; Nakayama S; Ishimatsu Y; Kawakami A; Eguchi K; Kohno S
    Chest; 2009 Nov; 136(5):1341-1347. PubMed ID: 19581351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review.
    Gil B; Merav L; Pnina L; Chagai G
    Clin Rheumatol; 2016 Aug; 35(8):2125-2130. PubMed ID: 25846833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal interstitial pulmonary fibrosis in anti-Jo-1-negative amyopathic dermatomyositis.
    High WA; Cohen JB; Murphy BA; Costner MI
    J Am Acad Dermatol; 2003 Aug; 49(2):295-8. PubMed ID: 12894081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.
    Koyama RVL; Braga TKK; da Silva Dias GA; Fujihara S; Fuzii HT; Yoshikawa GT
    Clin Rheumatol; 2017 Aug; 36(8):1919-1926. PubMed ID: 28488124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.
    Walling HW; Gerami P; Sontheimer RD
    Paediatr Drugs; 2010; 12(1):23-34. PubMed ID: 20034339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
    Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
    Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment challenges in clinically amyopathic dermatomyositis: A case series and review of new therapeutic options for skin involvement.
    Rodríguez-Tejero A; López-Espadafor B; Montero-Vílchez T; Sánchez-Díaz M; Arias-Santiago S; Molina-Leyva A
    Dermatol Ther; 2021 May; 34(3):e14942. PubMed ID: 33719170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases.
    Horai Y; Isomoto E; Koga T; Okada A; Kawashiri SY; Tamai M; Yamasaki S; Nakamura H; Origuchi T; Hamaguchi Y; Fujimoto M; Kuwana M; Kawakami A
    Mod Rheumatol; 2013 Jan; 23(1):190-4. PubMed ID: 22460910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological management of dermatomyositis.
    Griger Z; Nagy-Vincze M; Dankó K
    Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1109-1118. PubMed ID: 28691537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of clinically amyopathic dermatomyositis in adults: a systematic review.
    Callander J; Robson Y; Ingram J; Piguet V
    Br J Dermatol; 2018 Dec; 179(6):1248-1255. PubMed ID: 27167896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically Amyopathic Dermatomyositis Complicated by Pleural Effusion Case Report, Literature Review, and Proposed Mechanism.
    Wu Y; Chhaya S; Hurowitz B; Ardiles T; Carlson R
    Bull Hosp Jt Dis (2013); 2015 Jul; 73(3):217-20. PubMed ID: 26535603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.
    Koichi Y; Aya Y; Megumi U; Shunichi K; Masafumi S; Hiroaki M; Masahiko K; Shinsuke K; Manabu U; Kenichiro H; Fumiaki A; Nozomi A; Toshitaka M; Masayoshi Y; Chikako K; Yoshinao M; Tatsuo S; Masahiko K
    Mod Rheumatol; 2017 May; 27(3):536-540. PubMed ID: 25698373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
    Hozumi H; Fujisawa T; Nakashima R; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Inui N; Nakamura Y; Mimori T; Suda T
    J Rheumatol; 2019 May; 46(5):509-517. PubMed ID: 30647164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
    Kurita T; Yasuda S; Amengual O; Atsumi T
    Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.